Vaccinex, Inc. (VCNX)
OTCMKTS
· Delayed Price · Currency is USD
1.210
+0.200 (19.80%)
Dec 20, 2024, 4:00 PM EST
Vaccinex Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Revenue | 0.39 | 0.57 | 0.28 | 0.9 | 0.63 | 0.52 | Upgrade
|
| Revenue Growth (YoY) | -51.19% | 107.27% | -69.44% | 44.00% | 19.50% | -27.76% | Upgrade
|
| Cost of Revenue | 16.57 | 16.57 | 13.98 | 17.16 | 21.55 | 25.87 | Upgrade
|
| Gross Profit | -16.19 | -16 | -13.7 | -16.26 | -20.93 | -25.35 | Upgrade
|
| Selling, General & Admin | 6.96 | 6.88 | 6.2 | 6.23 | 7.41 | 6.67 | Upgrade
|
| Research & Development | -2.81 | - | - | - | - | - | Upgrade
|
| Operating Expenses | 4.15 | 6.88 | 6.2 | 6.23 | 7.41 | 6.67 | Upgrade
|
| Operating Income | -20.34 | -22.89 | -19.91 | -22.49 | -28.33 | -32.02 | Upgrade
|
| Interest Expense | - | -0 | -0 | -0.81 | -0.49 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 1.76 | 2.64 | 0.09 | 0.04 | -0.03 | 0.15 | Upgrade
|
| EBT Excluding Unusual Items | -18.58 | -20.25 | -19.82 | -23.26 | -28.85 | -31.86 | Upgrade
|
| Other Unusual Items | - | - | - | 0.88 | - | - | Upgrade
|
| Pretax Income | -18.58 | -20.25 | -19.82 | -22.38 | -28.85 | -31.86 | Upgrade
|
| Earnings From Continuing Operations | -18.58 | -20.25 | -19.82 | -22.38 | -28.85 | -31.86 | Upgrade
|
| Net Income | -18.58 | -20.25 | -19.82 | -22.38 | -28.85 | -31.86 | Upgrade
|
| Net Income to Common | -18.58 | -20.25 | -19.82 | -22.38 | -28.85 | -31.86 | Upgrade
|
| Shares Outstanding (Basic) | 2 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 2 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 480.32% | 129.44% | 47.10% | 53.56% | 45.85% | 146.59% | Upgrade
|
| EPS (Basic) | -12.02 | -43.68 | -98.05 | -162.91 | -322.50 | -519.47 | Upgrade
|
| EPS (Diluted) | -12.02 | -43.68 | -98.05 | -163.80 | -322.50 | -519.47 | Upgrade
|
| Free Cash Flow | -15.87 | -17.3 | -19.17 | -25.33 | -28.94 | -30.79 | Upgrade
|
| Free Cash Flow Per Share | -10.27 | -37.31 | -94.88 | -184.38 | -323.46 | -502.03 | Upgrade
|
| Operating Margin | -5241.24% | -4014.91% | -7238.55% | -2498.89% | -4532.96% | -6121.41% | Upgrade
|
| Profit Margin | -4787.89% | -3552.81% | -7205.45% | -2486.67% | -4616.16% | -6092.35% | Upgrade
|
| Free Cash Flow Margin | -4089.69% | -3035.26% | -6972.00% | -2814.44% | -4629.92% | -5887.76% | Upgrade
|
| EBITDA | -20.23 | -22.77 | -19.7 | -22.32 | -28.02 | -31.77 | Upgrade
|
| D&A For EBITDA | 0.1 | 0.12 | 0.21 | 0.17 | 0.31 | 0.25 | Upgrade
|
| EBIT | -20.34 | -22.89 | -19.91 | -22.49 | -28.33 | -32.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.